Avtor/Urednik		Salapura, Vladka; Šurlan, Miloš; Ključevšek, Tomaž; Klančar, Janez
Naslov		Predoperativna embolizacija ledvičnih tumorjev
Tip		članek
Vir		In: Kozak M, Blinc A, Šabovič M, editors. Žilne bolezni in rak; 2006 apr; Šmarješke toplice. Ljubljana: Združenje za žilne bolezni,
Leto izdaje		2006
Obseg		str. 43-9
Jezik		slo
Abstrakt		Malignant renal tumors consistute the majority of renal masses encountered in clinical practice. Malignant neoplasms of the kidney include primary renal tumors or secondary tumors of the kidney. Metastases are twice as common as primary tumors. The most common primary renal malignancy is adenocarcinoma, followed by carcinoma of the urothelium, Wilms tumor and sarcomas. Renal cell carcinoma is usually confirmed by ultrasound, CT, CT or MR angiography (CTA, MRA) and digital subtraction angiography (DSA). Conventional therapy for renal cell carcinoma is open nephrectomy. However, less invasive ways of treatment, such as endovascular embolization of renal tumors, have been developed, primarily for the patients who are poor surgical candidates or have proven disseminated disease. Surgical treatment can also be performed after the preprocedural endovascular embolization of the renal tumor, to reduce the intraoperative blood loss. The newest less invasive percutaneous treatment is radiofrequency ablation (RFA), which can be performed independently or after the previous endovascular embolization of the tumor mass.
Deskriptorji		KIDNEY NEOPLASMS EMBOLIZATION, THERAPEUTIC CATHETER ABLATION